Health Canada approves Janssen’s type 2 diabetes mellitus medication
Johnson & Johnson subsidiary Janssen has announced Health Canada's approval for Invokana (canagliflozin), indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Canagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Health | Invokana | Nutrition | Pharmaceuticals | Sports Medicine